Open AccessTo the question of the use of alimamazine (Teraligen®) in patients with atopic dermatitis in combination with anxiety-depressive disorder
Author(s) -
A. S. Edin
Publication year - 2018
Publication title -
consilium medicum
Language(s) - English
Resource type - Journals
eISSN - 2542-2170
pISSN - 2075-1753
DOI - 10.26442/2075-1753_2018.2.145-150
Subject(s) - atopic dermatitis , anxiety , dermatology , psychology , medicine , psychiatry , clinical psychology